MACC1 and breast cancer: Similarly, Tan et al. [29] studied the serum level of MACC1 by enzyme-linked immunosorbent assay (ELISA) and reported that MACC1 serum levels were higher in BC patients than the control and, consequently, it had a poor prognostic value.